1
|
Xie T, Hua BJ and Sun M: Clinical
progression in β-elemene research. Chin J Clin Oncol. 36:222009.(In
Chinese).
|
2
|
Adio AM: (-)-trans-β-Elemene and related
compounds: occurrence, synthesis, and anticancer activity.
Tetrahedron. 65:5145–5159. 2009.
|
3
|
Damstrup L, Rygaard K, Spang-Thomsen M and
Skovgaard Poulsen H: Expression of transforming growth factor beta
(TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and
TGF beta 3 in human small cell lung cancer cell lines. Br J Cancer.
67:1015–1102. 1993. View Article : Google Scholar : PubMed/NCBI
|
4
|
Gordon KJ and Blobe GC: Role of
transforming growth factor-beta superfamily signaling pathways in
human disease. Biochim Biophys Acta. 1782:197–228. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kamiya Y, Miyazono K and Miyazawa K: Smad7
inhibits transforming growth factor-beta family type I receptors
through two distinct modes of interaction. J Biol Chem.
285:30804–30813. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Yang X and Zhang YG: Research progress in
relationship between Smads and organ fibrosis. Medical
Recapitulate. 17:112011.(In Chinese).
|
7
|
Li ZZ and Li Q: TGF-β/Smads signal pathway
and its role in tumor. Medical Recapitulate. 17:62011.(In
Chinese).
|
8
|
Lagna G, Hata A, Hemmati-Brivanlou A, et
al: Partnership between DPC4 and SMAD proteins in TGF-beta
signalling pathways. Nature. 383:832–836. 1996. View Article : Google Scholar : PubMed/NCBI
|
9
|
Cao B, Jiang MC, Lei ZY, et al: Effects of
PLAB on apoptosis and Smad signal pathway of hypertrophic scar
fibroblasts. J Asian Nat Prod Res. 10:147–157. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Li GQ, Xie BB, Chen YH, Li XL and Zou LJ:
A research on adiotherapy sensitization by β-elemene on human
adenocarcinoma implanted in naked mice and its correlation with
HIF-1α CAIX. Chin J Clin Oncol. 38:62011.(In Chinese).
|
11
|
Liu J, Lo ZH, Liu YP, Qu XJ, Hou KZ, Xu L
and Zhang Y: Influence of β-elemene on apoptosis of gastric cancer
MGC803 cells and the mechanism. Shandong Medical Journal.
37:72010.(In Chinese).
|
12
|
Gao C and Wu R: A meta-analysis on
β-elemene in single dosage or combination with
chemotherapy/radiotherapy to treat brain malignancies. Chin J Clin
Oncol. 37:72010.(In Chinese).
|
13
|
Li GQ, Xie BB, Chen YH, Li XL and Zou LJ:
A research on correlation between radiotherapy sensitized by
β-elemene and tumor vascularization. The Practical Journal of
Cancer. 26:12011.(In Chinese).
|
14
|
Li LJ, Zou LJ, Zhang Z and Wang Q: The
effect of β-elemene combined with radiation on DNA damage and
repair in A549 cells. Chinese Journal of Radiation Oncology.
20:355–357. 2011.(In Chinese).
|
15
|
Li GQ, Li XL, Xie BB, Chen YH, Lei HW and
Zou LJ: Study on the radiosensitivity of nude mice model
transplanted lung adenocarcinoma cell treated by β-elemene. Chinese
Journal of Radiological Medicine and Protection. 30:687–691.
2010.(In Chinese).
|
16
|
Li QQ, Wang G, Huang F, Banda M and Reed
E: Antineoplastic effect of beta-elemene on prostate cancer cells
and other types of solid tumour cells. J Pharm Pharmacol.
62:1018–1027. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhan YH, Liu ZY, Liu J, Liu YP, Qu XJ, Hou
KZ and Wu B: An exploration on β-elemene influence of on kidney
cancer 786–0 cells and its mechanism. Shandong Medical Journal.
51:302011.(In Chinese).
|
18
|
Samanta D and Datta PK: Alterations in the
Smad pathway in human cancers. Front Biosci. 17:1281–1293. 2012.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Lampropoulos P, Zizi-Sermpetzoglou A,
Rizos S, et al: TGF-beta signalling in colon carcinogenesis. Cancer
Lett. 314:1–7. 2012. View Article : Google Scholar
|
20
|
Kretschmer C, Conradi A, Kemmner W and
SternerKock A: Latent transforming growth factor binding protein 4
(LTBP4) is down regulated in mouse and human DCIS and mammary
carcinomas. Cell Oncol (Dordrecht). 34:419–434. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhu T, Xu Y, Dong B, Zhang J, Wei Z, Xu Y
and Yao Y: β-elemene inhibits proliferation of human glioblastoma
cells through the activation of glia maturation factor β and
induces sensitization to cisplatin. Oncol Rep. 26:405–413.
2011.
|
22
|
Chen WX, Lu Y, Wu JM, Gao M, Wang AY and
Xu B: Beta-elemene inhibits melanoma growth and metastasis via
suppressing vascular endothelial growth factor-mediated
angiogenesis. Cancer Chemother Pharmacol. 67:799–808. 2011.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Zhu TZ, Zhao YS, Zhang JN, Li LJ, Zou LJ,
Yao YQ and Xu YH: β-Elemene inhibits proliferation of human
glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually
compensatory activation of MKK3 and MKK6. Int J Oncol. 38:419–426.
2011.
|
24
|
Li QQ, Wang G, Zhang M, Cuff CF, Huang L
and Reed E: beta-Elemene, a novel plant-derived antineoplastic
agent, increases cisplatin chemosensitivity of lung tumor cells by
triggering apoptosis. Oncol Rep. 22:161–170. 2009.PubMed/NCBI
|
25
|
Liu J, Hu XJ, Jin B, Qu XJ, Hou KZ and Liu
YP: β-Elemene induces apoptosis as well as protective autophagy in
human non-small-cell lung cancer A549 cells. J Pharm Pharmacol.
64:146–153. 2012.
|
26
|
Li L, Xu L, Qu XJ, et al: Cbl-regulated
Akt and ERK signals are involved in β-elemene-induced cell
apoptosis in lung cancer cells. Mol Med Rep. 4:1243–1246.
2011.PubMed/NCBI
|
27
|
Ying J, Yang W, Xie CY, et al: Induction
of caspase-3-dependent apoptosis in human leukemia HL-60 cells by
δ-elemene. Yakugaku Zasshi. 131:1383–1394. 2011.
|